AFFILIN - Trademark Details
Status: 700 - Registered
Serial Number
79155885
Registration Number
4838850
Word Mark
AFFILIN
Status
700 - Registered
Status Date
2015-10-27
Filing Date
2014-07-29
Registration Number
4838850
Registration Date
2015-10-27
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2015-08-11
Attorney Name
Law Office Assigned Location Code
M90
Employee Name
HUSSAIN, TASNEEM
Statements
Goods and Services
Chemicals used in industry and science, in particular comprising antibody-like proteins or artificial proteins, except finishing agents for the preparation of synthetic and natural fibres; polypeptides and proteins for industrial purposes, including the manufacturing and purification of proteins, polypeptides, chemicals and other substances; diagnostic and analytic preparations for scientific or research use, not for medical or veterinary use; chemical reagents for analysis in laboratories, not for medical or veterinary use; biological tissue cultures for laboratories, not for medical or veterinary use; biological tissue cultures for laboratory analysis and diagnostics other than for medical or veterinary purposes
Goods and Services
Pharmaceutical and veterinary preparations for use in the treatment of cystic fibrosis, psychosomatic diseases, depression, epilepsy, endocrinologic disorders, cirrhoses, diseases associated with hormonal disturbances, autoimmune diseases, eye diseases, obesity, metabolic diseases, stroke, infectious diseases, cancer, degenerative diseases, neurodegenerative diseases, asthmatic diseases, dermatologic diseases, musculoskeletal diseases, periodontosis, dental diseases, diabetes, cardiovascular diseases, inflammatory diseases, hematologic diseases, urologic diseases or erectile dysfunctions, psychological diseases, broncholytic diseases, pulmonary diseases, dermatological diseases, lipid metabolism disorders, migraine, dementia, rheumatic disorders, gastric and intestinal diseases, enzyme deficiency and transport proteins disorders, analeptic diseases, anoretic diseases, blood diseases, allergic diseases, anemic diseases, geriatric diseases, cold and flu, hepatic diseases, immunological diseases, cardiac diseases, skeletal and muscle diseases, osteoporosis, ontological diseases, mouth and pharyngeal diseases, asthmatic diseases, bile-duct disorders, and arteriosclerosis; medical therapeutic agents for use in the treatment of cystic fibrosis, psychosomatic diseases, depression, epilepsy, endocrinologic disorders, cirrhoses, diseases associated with hormonal disturbances, autoimmune diseases, eye diseases, obesity, metabolic diseases, stroke, infectious diseases, cancer, degenerative diseases, neurodegenerative diseases, asthmatic diseases, dermatologic diseases, musculoskeletal diseases, periodontosis, dental diseases, diabetes, cardiovascular diseases, inflammatory diseases, hematologic diseases, urologic diseases or erectile dysfunctions, psychological diseases, broncholytic diseases, pulmonary diseases, dermatological diseases, lipid metabolism disorders, migraine, dementia, rheumatic disorders, gastric and intestinal diseases, enzyme deficiency and transport proteins disorders, analeptic diseases, anoretic diseases, blood diseases, allergic diseases, anemic diseases, geriatric diseases, cold and flu, hepatic diseases, immunological diseases, cardiac diseases, skeletal and muscle diseases, osteoporosis, ontological diseases, mouth and pharyngeal diseases, asthmatic diseases, bile-duct disorders, and arteriosclerosis; biochemical therapeutic agents for use in the treatment of cystic fibrosis, psychosomatic diseases, depression, epilepsy, endocrinologic disorders, cirrhoses, diseases associated with hormonal disturbances, autoimmune diseases, eye diseases, obesity, metabolic diseases, stroke, infectious diseases, cancer, degenerative diseases, neurodegenerative diseases, asthmatic diseases, dermatologic diseases, musculoskeletal diseases, periodontosis, dental diseases, diabetes, cardiovascular diseases, inflammatory diseases, hematologic diseases, urologic diseases or erectile dysfunctions, psychological diseases, broncholytic diseases, pulmonary diseases, dermatological diseases, lipid metabolism disorders, migraine, dementia, rheumatic disorders, gastric and intestinal diseases, enzyme deficiency and transport proteins disorders, analeptic diseases, anoretic diseases, blood diseases, allergic diseases, anemic diseases, geriatric diseases, cold and flu, hepatic diseases, immunological diseases, cardiac diseases, skeletal and muscle diseases, osteoporosis, ontological diseases, mouth and pharyngeal diseases, asthmatic diseases, bile-duct disorders, and arteriosclerosis, except preparations containing theophylline; diagnostic and analytical preparations for medical and veterinary use; biological and chemical diagnostic reagents for medical use
Goods and Services
Scientific and industrial research in particular in the biological, biochemical, diagnostic and pharmaceutical fields; biochemistry and pharmaceutical laboratory services; scientific and technological services, namely, scientific research, analysis, testing, in particular in the biological, biochemical, diagnostic and pharmaceutical fields; industrial research and analysis, namely, services in development of biological, biochemical, pharmaceutical and diagnostic products; research for the identification and further development of biological, biochemical, pharmaceutical and diagnostic products
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2014-12-08
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2014-12-08
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2014-12-08
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Adam D. Mandell
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1225025
International Registration Date
2014-07-29
International Publication Date
2014-12-04
International Renewal Date
2024-07-29
Auto Protection Date
2016-06-04
International Status
001 - Request for extension of protection established
International Status Date
2014-12-04
Priority Claimed In
False
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2014-12-04 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2014-12-08 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2014-12-08 | ASSIGNED TO EXAMINER |
| 2014-12-08 | NON-FINAL ACTION WRITTEN |
| 2014-12-09 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2014-12-10 | REFUSAL PROCESSED BY MPU |
| 2014-12-10 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2014-12-12 | APPLICATION FILING RECEIPT MAILED |
| 2014-12-27 | REFUSAL PROCESSED BY IB |
| 2015-06-10 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2015-06-17 | ASSIGNED TO LIE |
| 2015-06-24 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2015-06-24 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2015-07-06 | EXAMINERS AMENDMENT -WRITTEN |
| 2015-07-06 | EXAMINERS AMENDMENT E-MAILED |
| 2015-07-06 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2015-07-06 | EXAMINER'S AMENDMENT ENTERED |
| 2015-07-07 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2015-07-08 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2015-07-22 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2015-08-05 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2015-08-05 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2015-08-11 | PUBLISHED FOR OPPOSITION |
| 2015-08-11 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2015-08-21 | NOTIFICATION PROCESSED BY IB |
| 2015-10-27 | REGISTERED-PRINCIPAL REGISTER |
| 2016-01-27 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2016-05-12 | FINAL DISPOSITION PROCESSED |
| 2016-05-12 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2016-07-15 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2020-10-27 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 2021-10-26 | TEAS SECTION 71 RECEIVED |
